164 related articles for article (PubMed ID: 22127407)
1. Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.
Sofroniadou S; Kassimatis T; Srirajaskanthan R; Reidy J; Goldsmith D
Int Urol Nephrol; 2012 Oct; 44(5):1451-9. PubMed ID: 22127407
[TBL] [Abstract][Full Text] [Related]
2. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
[TBL] [Abstract][Full Text] [Related]
3. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
4. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
[TBL] [Abstract][Full Text] [Related]
5. Use of renin-angiotensin inhibitors in people with renal artery stenosis.
Evans KL; Tuttle KR; Folt DA; Dawson T; Haller ST; Brewster PS; He W; Jamerson K; Dworkin LD; Cutlip DE; Murphy TP; D'Agostino RB; Henrich W; Cooper CJ
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1199-206. PubMed ID: 24903387
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
[TBL] [Abstract][Full Text] [Related]
8. Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
Moriyama T; Amamiya N; Ochi A; Tsuruta Y; Shimizu A; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
Clin Exp Nephrol; 2011 Oct; 15(5):700-707. PubMed ID: 21625892
[TBL] [Abstract][Full Text] [Related]
9. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
[TBL] [Abstract][Full Text] [Related]
10. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Renin-Angiotensin-Aldosterone System in Elderly Patients with Heart Failure and Chronic Kidney Disease: Results of a Single-Center, Observational Cohort Study.
Martínez-Milla J; García MC; Urquía MT; Castillo ML; Arbiol AD; Monteagudo ALR; Mariscal MLM; Figuero SB; Franco-Pelaéz JA; Tuñón J
Drugs Aging; 2019 Dec; 36(12):1123-1131. PubMed ID: 31493202
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone system blockade and arterial stiffness in renal transplant recipients - a cross-sectional prospective observational clinical study.
Heleniak Z; Illersperger S; Brakemeier S; Bach P; Dębska-Ślizień A; Budde K; Halleck F
Acta Biochim Pol; 2020 Dec; 67(4):613-622. PubMed ID: 33332078
[TBL] [Abstract][Full Text] [Related]
15. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
Voskamp PWM; Dekker FW; van Diepen M; Hoogeveen EK;
J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
Lin CC; Wu YT; Yang WC; Tsai MJ; Liu JS; Yang CY; Li SY; Ou SM; Tarng DC; Hsu CC
PLoS One; 2017; 12(12):e0189126. PubMed ID: 29216260
[TBL] [Abstract][Full Text] [Related]
17. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
Opelz G; Döhler B
Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
